| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Herskowitz Neil serves as a Director at DERM and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 19 buys and 2 sells. Those positions are worth an estimated $333 at current prices.
The biggest single holding is ATXI (~$194) as Director. Net of sales, the recent Form 4 record there shows accumulation of 50,038 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | MBIO Mustang Bio, Inc. | Director | Sell | 247 | $0.96 | $237.61 | -63.0% | -23.7% | - | |
| Dec 2, 2024 | ATXI Avenue Therapeutics, Inc. | Director | Sell | 23 | $2.00 | $46.00 | -19.2% | - | - | |
| May 6, 2021 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 2,500 | $3.99 | $9,975.00 | +1.9% | - | - | |
| Feb 27, 2020 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 2,561 | $8.23 | $21,085.53 | +2.1% | - | - | |
| Feb 25, 2020 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 10,000 | $9.31 | $93,100.00 | +9.1% | - | - | |
| Jun 18, 2019 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 5,000 | $5.86 | $29,300.00 | +5.3% | - | - | |
| Apr 15, 2019 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 1,000 | $4.52 | $4,520.00 | +1.1% | - | - | |
| Mar 29, 2019 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 2,000 | $5.11 | $10,220.00 | +2.2% | - | - | |
| Feb 25, 2019 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 5,000 | $5.46 | $27,300.00 | +5.8% | - | - | |
| Feb 5, 2019 | ATXI Avenue Therapeutics, Inc. | Director | Buy | 8,850 | $5.88 | $52,044.50 | +11.4% | - | - |